Peptide Systems

Peptide Systems

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Peptide Systems is a long-established, private supplier of research-grade peptides and small molecules, serving the preclinical and basic research markets. Its core value proposition is guaranteed purity and precision, validated by independent, ISO-certified lab certifications for all its products. The company operates a B2B services model, generating revenue by supplying essential tools to academic, pharmaceutical, and biotech researchers. While not a therapeutic developer itself, it supports drug discovery pipelines by providing critical starting materials and enabling early-stage research.

PeptidesDrug DeliverySmall Molecules

Technology Platform

Integrated quality assurance and supply chain system for peptide/small molecule synthesis, with third-party ISO-certified laboratory validation for all products.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

Growing demand for high-quality, reproducible research materials supports its value proposition.
Expansion into new geographic markets and adjacent product categories (e.g., complex modified peptides, drug delivery components) presents avenues for growth.

Risk Factors

Intense competition from large, diversified reagent suppliers and low-cost producers.
Reliance on third-party labs and complex supply chains introduces operational risk.
Demand is tied to cyclical R&D funding in academia and biopharma.

Competitive Landscape

Highly competitive and fragmented, ranging from global giants like Thermo Fisher and Merck KGaA to specialized peptide manufacturers like Bachem and numerous small-scale suppliers. Differentiation is primarily based on price, purity, catalog breadth, and speed, with Peptide Systems competing on certified quality.